EXCLUSIVE: Context Therapeutics Co-Founder & CEO, Martin Lehr Now Interviewing On Benzinga’s ‘All-Access’ Show

Click To Tune In Here… https://www.youtube.com/watch?v=vLBRC8C_X3o

byBenzinga Newsdesk

August 12, 2022

1 minute read

Click To Tune In Here… https://www.youtube.com/watch?v=vLBRC8C_X3o

EXCLUSIVE: Tilray CEO Shares Insider Insights Into Earnings, International Opportunities, Alcohol Market & More

By Jelena Martinovic

Today, 2:51 PM

Tilray Brands Inc.'s (NASDAQ: TLRY) CEO Irwin Simon said on Thursday's "Cannabis Insider" that "Europe will legalize [cannabis] before the U.S."

CSE:MMEN

Benzinga Announces This Week’s All Access Guests

By Kenneth Adams

Today, 2:51 PM

Benzinga is thrilled to announce the guest lineup for our next All Access show, presented by RedChip, set to air Friday, January 28 at 9:15 am ET. The Lineup 9:15 am: Opening Remarks with RedChip

BRAG

EXCLUSIVE: PLBY Group CEO, Ben Kohn Says Licensing Is Progressing In The Co, But COVID-19 Slowed Down The Co’s Licensing Business, Says We Really Believe In India In The Long-Term

By Benzinga Newsdesk

Today, 2:51 PM

https://www.youtube.com/watch?v=ifhdUfu6Cog

PLBY

Gene Munster And Gordon Johnson Actually Agree On Something: A Tesla Stock Split

By Adam Eckert

Today, 2:51 PM

Loup Funds' Gene Munster and GLJ Research's Gordon Johnson are well known for taking opposing views when it comes to Tesla Inc (NASDAQ: TSLA). However, it seems the Tesla bull and bear are finally in agreement.

TSLA

EXCLUSIVE: Context Therapeutics Co-Founder & CEO, Martin Lehr Now Interviewing On Benzinga’s ‘All-Access’ Show

Related Posts

EXCLUSIVE: Tilray CEO Shares Insider Insights Into Earnings, International Opportunities, Alcohol Market & More

Benzinga Announces This Week’s All Access Guests

EXCLUSIVE: PLBY Group CEO, Ben Kohn Says Licensing Is Progressing In The Co, But COVID-19 Slowed Down The Co’s Licensing Business, Says We Really Believe In India In The Long-Term

Gene Munster And Gordon Johnson Actually Agree On Something: A Tesla Stock Split